文献速递瓣膜外科

成人心脏手术中的肝素结合蛋白

Heparin Binding Protein in Adult Heart Surgery.
PubMed 文献 · Ann Thorac Surg · 2018-11-14

该研究在30例主动脉瓣置换患者中,于主动脉阻断前和再灌注后5分钟同步采集冠状静脉窦与动脉血,计算跨冠状动脉差值。结果显示体外循环后动脉肝素结合蛋白(HBP)从术前4.1 ng/mL升至150.0 ng/mL,再灌注期间跨冠状动脉HBP释放与中性粒细胞滞留及心肌损伤标志物释放同时出现。

要点

  • 体外循环导致循环HBP大幅升高,术后达150.0 ng/mL。
  • 再灌注时冠状循环释放HBP,伴中性粒细胞滞留和心肌损伤。
  • HBP可能是体外循环毛细血管渗漏的候选体液因子。

核心结论

  • 体外循环导致循环HBP显著升高,再灌注冠状循环释放HBP并与中性粒细胞黏附及心肌损伤同时发生。
  • HBP可能是介导体外循环毛细血管渗漏的候选体液因子。

研究设计与样本

  • 前瞻性观察研究,纳入30例接受主动脉瓣置换的成人患者。
  • 于主动脉阻断前和再灌注后5分钟同步采集冠状静脉窦与动脉血,计算跨冠状动脉差值。

主要发现

  • 动脉HBP术前为4.1 ng/mL(IQR 3.6-5.3 ng/mL),主动脉开放后为150.0 ng/mL(IQR 108.2-188.6 ng/mL)。
  • 体外循环期间HBP升高39倍,乳铁蛋白升高16倍,髓过氧化物酶升高4倍。
  • 再灌注期间跨冠状动脉HBP释放为6.4 ng/mL(IQR 1.8-13.7 ng/mL,p<0.001)。
  • 再灌注期间跨冠状动脉中性粒细胞滞留为-0.14×10^9/L(IQR -0.28-0.01×10^9/L,p=0.001)。
  • 再灌注期间跨冠状动脉心脏型脂肪酸结合蛋白释放为6.9 ng/mL(IQR 3.0-25.8 ng/mL,p<0.001)。

临床怎么用

  • 心脏外科体外循环围术期可关注HBP作为毛细血管渗漏的潜在监测指标。
  • 再灌注期HBP释放与心肌损伤标志物同步,提示其参与再灌注相关炎症反应。

局限性

  • 样本量仅30例,仅涉及主动脉瓣置换患者。
  • 仅评估再灌注后5分钟单时间点,未提供长期结局数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heparin binding protein (HBP) is released from neutrophilic secretory vesicles upon neutrophil adhesion on the endothelium. HBP mediates capillary hyperpermeability experimentally. In sepsis, HBP predicts organ dysfunction. Cardiopulmonary bypass induces neutrophil activation and hyperpermeability. We hypothesized that in cardiopulmonary bypass, HBP is released in the reperfused coronary circulation concomitantly with neutrophil adhesion. METHODS: In 30 patients undergoing aortic valve replacement, concomitant blood samples were drawn from the coronary sinus and arterial line before aortic cross-clamping and 5 minutes after reperfusion to calculate transcoronary differences. Plasma HBP concentrations, neutrophil markers lactoferrin and myeloperoxidase, myocardial injury marker heart-type fatty acid binding protein, and leukocyte differential counts were measured. RESULTS: Arterial HBP was 4.1 ng/mL (interquartile range [IQR], 3.6 to 5.3 ng/mL) preoperatively and 150.0 ng/mL (IQR, 108.2 to 188.6 ng/mL) after aortic declamping. HBP increased 39-fold, lactoferrin 16-fold, and myeloperoxidase fourfold during cardiopulmonary bypass. Before cardiopulmonary bypass, there were marginal transcoronary differences in HBP (1.4 ng/mL; IQR, -0.4 to 3.6 ng/mL; p = 0.001) and heart-type fatty acid binding protein (0.4 ng/mL; IQR, -0.04 to 3.5 ng/mL; p = 0.001) but not in the other indicators. During reperfusion, transcoronary HBP release (6.4 ng/mL; IQR, 1.8 to 13.7; ng/mL; p < 0.001) was observed concomitantly with transcoronary neutrophil sequestration (-0.14 × 109/L; IQR, -0.28 to 0.01 × 109/L; p = 0.001) and transcoronary heart-type fatty acid binding protein release (6.9 ng/mL; IQR, 3.0 to 25.8 ng/mL; p < 0.001). There were no transcoronary differences in lactoferrin or myeloperoxidase during reperfusion. CONCLUSIONS: Cardiopulmonary bypass results in substantial increase in circulating HBP. HBP is also released from the reperfused coronary circulation concomitantly with coronary neutrophil adhesion and myocardial injury. HBP may be one candidate for a humoral factor mediating capillary leak in cardiopulmonary bypass.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Pesonen E, Passov A, Salminen US, et al. Heparin Binding Protein in Adult Heart Surgery. Ann Thorac Surg. 2018. PMID: 30447193. doi:10.1016/j.athoracsur.2018.10.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。